FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma

To estimate the value of FSCN1 in evaluating the prognosis and guiding the targeted therapy for patients with tongue squamous cell carcinoma (TSCC). Using the Oncomine database, we found some genes especially FSCN1 differentially expressed between TSCC samples and tongue normal samples. So we compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yue, Tian, Tian, Li, Zhi-Yong, Wang, Chun-Yang, Deng, Rong, Deng, Wei-Ye, Yang, An-kui, Chen, Yan-Feng, Li, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494834/
https://www.ncbi.nlm.nih.gov/pubmed/31043585
http://dx.doi.org/10.1038/s41419-019-1574-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494834/
https://www.ncbi.nlm.nih.gov/pubmed/31043585
http://dx.doi.org/10.1038/s41419-019-1574-5

Ejemplares similares